Anne Gry Bentzen

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García et al. · The Lancet · 2023 · 175 citations

Oncology, Cervical Cancer, Metronomic Therapy +6

Impaired health-related quality of life after chemoradiotherapy for anal cancer: Late effects in a national cohort of 128 survivors

Anne Gry Bentzen, Lise Balteskard, Eva Hoff Wanderås et al. · Acta Oncologica · 2013 · 136 citations · Full text

Faecal incontinence after chemoradiotherapy in anal cancer survivors: Long-term results of a national cohort

Anne Gry Bentzen, Marianne G. Guren, Barthold Vonen et al. · Radiotherapy and Oncology · 2013 · 77 citations

Urology, Surgical Oncology, Anal Cancer Survivors +8

Chemoradiotherapy of Anal Carcinoma: Survival and Recurrence in an Unselected National Cohort

Anne Gry Bentzen, Marianne G. Guren, Eva Hoff Wanderås et al. · International Journal of Radiation Oncology*Biology*Physics · 2012 · 53 citations

Surgical Oncology, Radiation Therapy, Gastrointestinal Oncology +8

A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway

Ingvild Vistad, Line Bjørge, Olesya Solheim et al. · Acta Obstetricia Et Gynecologica Scandinavica · 2017 · 35 citations · Full text